Lithium, a Potential Protective Drug in Alzheimer’s Disease
- 1 March 2008
- journal article
- review article
- Published by S. Karger AG in Neurodegenerative Diseases
- Vol. 5 (3-4), 247-249
- https://doi.org/10.1159/000113715
Abstract
Alzheimer's disease is characterized by the presence of two histopathological aberrant structures, the senile plaques and the neurofibrillary tangles. The main component of these tangles is the cytoskeletal protein tau in hyperphosphorylated form. Since a main tau kinase is glycogen synthase kinase 3 (GSK-3), the use of specific GSK-3 inhibitors, like lithium, could be a potential therapy in Alzheimer's disease. In this short article, we have done a review on tau phosphorylation in Alzheimer's disease and other tauopathies, and on the inhibition of kinases like GSK-3, involved in tau modification.Keywords
This publication has 18 references indexed in Scilit:
- Lithium Reduces Tau Phosphorylation but Not Aβ or Working Memory Deficits in a Transgenic Model with Both Plaques and TanglesThe American Journal of Pathology, 2007
- Multiple-motor based transport and its regulation by TauProceedings of the National Academy of Sciences, 2007
- Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivoNature, 2006
- Chronic lithium administration to FTDP‐17 tau and GSK‐3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre‐formed neurofibrillary tangles do not revertJournal of Neurochemistry, 2006
- Full Reversal of Alzheimer's Disease-Like Phenotype in a Mouse Model with Conditional Overexpression of Glycogen Synthase Kinase-3Journal of Neuroscience, 2006
- Cooexpression of FTDP-17 tau and GSK-3β in transgenic mice induce tau polymerization and neurodegenerationNeurobiology of Aging, 2005
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Glycogen synthase kinase 3: a drug target for CNS therapiesJournal of Neurochemistry, 2004
- Role of Tau Protein in Both Physiological and Pathological ConditionsPhysiological Reviews, 2004
- Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.Brain Research Reviews, 2000